<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="87463">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02062151</url>
  </required_header>
  <id_info>
    <org_study_id>Acupuncture</org_study_id>
    <nct_id>NCT02062151</nct_id>
  </id_info>
  <brief_title>Acupuncture in Neonatal Abstinence Syndrome (NAS) Babies</brief_title>
  <official_title>Acupuncture Use in Infants Treated for Neonatal Abstinence Syndrome: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of South Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of South Florida</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This pilot study is intended to assess feasibility of auricular acupuncture in NAS infants
      who require pharmacologic therapy at Tampa General Hospital (TGH). We intend to evaluate
      acceptability of auricular acupuncture, infant tolerance, recruitment strategies, and
      methodological issues. We plan to also test and generate hypotheses in preparation to apply
      for funding a larger randomized controlled trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives:

      Primary: To establish feasibility of a protocol for auricular acupuncture in infants
      suffering from NAS admitted to the NICU receiving pharmacologic therapy.

      Secondary: In infants suffering from NAS admitted to the Neonatal Intensive Care Unit (NICU)
      receiving pharmacologic therapy:

        1. Determine parent and staff acceptability of auricular acupuncture

        2. Determine infant tolerance to auricular acupuncture

        3. Evaluate the effect of auricular acupuncture on individual items of the Modified
           Finnegan Neonatal Abstinence Severity score associated with sympathetic nervous system
           responses

        4. Evaluate the effect of auricular acupuncture on time to return to birth weight
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2014</start_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Utilizing auricular acupuncture as an adjunctive treatment in NAS infants requiring pharmacologic therapy will be feasible.</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>NAS</condition>
  <arm_group>
    <arm_group_label>NAS babies</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>Acupuncture</description>
    <arm_group_label>NAS babies</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Gestational age â‰¥37.0 wks assessed by the obstetrical team from dating of last
             menstrual period, ultrasound, or best obstetric estimate

          2. Admitted to TGH's NICU with diagnosis of NAS requiring pharmacologic therapy

          3. Parents give written consent within 72 hours of infant receiving first dose of
             methadone

        Exclusion Criteria:

          1. Helix or antihelix of ear is deformed and needle is unable to be placed

          2. A suspected or confirmed genetic or metabolic syndrome

          3. Custody retained by the Department of Children and Families

          4. Any skin condition involving the ear(s)

          5. Suspected or documented infection at the time of enrollment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laura Weathers, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>USF</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shari Roberts, MSN</last_name>
    <phone>813-844-3395</phone>
    <email>srobert3@health.usf.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Judy Zaritt, BSN</last_name>
    <phone>813-844-3046</phone>
    <email>jzaritt@health.usf.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tampa General Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Weathers</last_name>
      <email>lweathe1@health.usf.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 10, 2014</lastchanged_date>
  <firstreceived_date>February 5, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of South Florida</investigator_affiliation>
    <investigator_full_name>Laura Weathers</investigator_full_name>
    <investigator_title>Associate Professor of Pediatrics, Division of General Pediatrics</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neonatal Abstinence Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
